Propofol and survival: an updated meta-analysis of randomized clinical trials.

Yuki KotaniAlessandro PrunaStefano TuriGiovanni BorghiTodd C LeeAlberto ZangrilloGiovanni LandoniLaura Pasin

Published in: Critical care (London, England) (2023)

Propofol may reduce survival in perioperative and critically ill patients. This needs careful assessment of the risk versus benefit of propofol compared to other agents while planning for large, pragmatic multicentric randomized controlled trials to provide a definitive answer.

Keyphrases

systematic review
meta analyses
randomized controlled trial
free survival
patients undergoing
study protocol
cardiac surgery
radiation therapy
locally advanced